Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andrews F. J., Morris C. J., Kondratowicz G., Blake D. R. Effect of iron chelation on inflammatory joint disease. Ann Rheum Dis. 1987 Apr;46(4):327–333. doi: 10.1136/ard.46.4.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blake D. R., Hall N. D., Bacon P. A., Dieppe P. A., Halliwell B., Gutteridge J. M. The importance of iron in rheumatoid disease. Lancet. 1981 Nov 21;2(8256):1142–1144. doi: 10.1016/s0140-6736(81)90590-0. [DOI] [PubMed] [Google Scholar]
- Font J., Coca A., Molina R., Ballesta A., Cardellach F., Ingelmo M., Balague A., Balcells A. Serum beta 2-microglobulin as a marker of activity in systemic lupus erythematosus. Scand J Rheumatol. 1986;15(2):201–205. doi: 10.3109/03009748609102089. [DOI] [PubMed] [Google Scholar]
- Fudman E. J., Till G. O., Fox I. H. Deferoxamine induced decreases of lipid peroxides in rheumatoid arthritis. J Rheumatol. 1987 Aug;14(4):686–691. [PubMed] [Google Scholar]
- Giordano N., Sancasciani S., Borghi C., Fioravanti A., Marcolongo R. Antianemic and potential anti-inflammatory activity of desferrioxamine: possible usefulness in rheumatoid arthritis. Clin Exp Rheumatol. 1986 Jan-Mar;4(1):25–29. [PubMed] [Google Scholar]
- KEBERLE H. THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM. Ann N Y Acad Sci. 1964 Oct 7;119:758–768. doi: 10.1111/j.1749-6632.1965.tb54077.x. [DOI] [PubMed] [Google Scholar]
- Manicourt D., Brauman H., Orloff S. Plasma and urinary levels of beta2 microglobulin in rheumatoid arthritis. Ann Rheum Dis. 1978 Aug;37(4):328–332. doi: 10.1136/ard.37.4.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Polson R. J., Jawad A. S., Bomford A., Berry H., Williams R. Treatment of rheumatoid arthritis with desferrioxamine. Q J Med. 1986 Dec;61(236):1153–1158. [PubMed] [Google Scholar]
- Rowley D., Gutteridge J. M., Blake D., Farr M., Halliwell B. Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clin Sci (Lond) 1984 Jun;66(6):691–695. doi: 10.1042/cs0660691. [DOI] [PubMed] [Google Scholar]
- Sato A., Bacon P. E., Cory J. G. Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit. Adv Enzyme Regul. 1984;22:231–241. doi: 10.1016/0065-2571(84)90016-5. [DOI] [PubMed] [Google Scholar]
- Senator G. B., Muirden K. D. Concentration of iron in synovial membrane, synovial fluid, and serum in rheumatoid arthritis and other joint diseases. Ann Rheum Dis. 1968 Jan;27(1):49–54. doi: 10.1136/ard.27.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]